SAFE-PLASMA Protocol

Ce que l'acheteur demande

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.

Langue de cet avis : English. Le titre et la description sont affichés tels que publiés par l'acheteur.

How this compares

• Bidders were given 6 days from publication to the deadline; the median for open tenders in États-Unis is 18 days.

More open tenders from this buyer